Thus, our analysis suggests the hypothesis that DVL3 amplifications, coupled with decrease in CXXC4 expression, could drive ovarian cancer progression through enhanced activation of the Wnt signaling pathway. The gene discussed is CXXC4; the disease is ovarian cancer.